Columbia Tribune: Website espouses medical benefits of psychedelic drugs

Amber Lyon used psychedelic medicines to cure anxiety and PTSD. She founded, to produce and aggregate journalism on the medicines.


by Ashley Jost

on May 28, 2014

Amber Lyon was frustrated by what she saw as the lack of reporting and published information in general on the effects of an array of psychedelic drugs but chose to treat that as an opportunity.

Lyon, a University of Missouri alumna and former reporter for CNN, plans to launch her new project,, this week. It’s a news outlet solely for original and aggregate reporting on the benefits of psychedelics.

During her time as a reporter, Lyon covered war and sex trafficking, among other tumultuous subjects. After a decade of constant negativity and stress, Lyon said, she was suffering from post-traumatic stress disorder. A friend recommended she try psychedelics to help eliminate her bottled-up stressors.

“At first I laughed because I had grown up in the Midwest and grouped all drugs as being, well, drugs,” she said, “when, in fact, some should be grouped or scheduled as medicines.”

Hours of research later, Lyon decided to give it a shot. She traveled the world for a year, testing an array of “medicines” to help with her psychological issues. First was ayahuasca, a cocktail of juices from a vine native to parts of South America, as well as dimethyltryptamine, a hallucinogen. Later, she tried mushrooms.

Click here to read the full article